CN108686023A - A kind of antipruritic moisturizing essential oil for treating geroderma itch - Google Patents
A kind of antipruritic moisturizing essential oil for treating geroderma itch Download PDFInfo
- Publication number
- CN108686023A CN108686023A CN201810926128.9A CN201810926128A CN108686023A CN 108686023 A CN108686023 A CN 108686023A CN 201810926128 A CN201810926128 A CN 201810926128A CN 108686023 A CN108686023 A CN 108686023A
- Authority
- CN
- China
- Prior art keywords
- essential oil
- antipruritic
- trichosanthes
- emollient
- licorice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 158
- 208000003251 Pruritus Diseases 0.000 title claims abstract description 55
- 230000001139 anti-pruritic effect Effects 0.000 title claims abstract description 23
- 239000003908 antipruritic agent Substances 0.000 title claims abstract description 23
- 230000003020 moisturizing effect Effects 0.000 title abstract description 4
- 239000003814 drug Substances 0.000 claims abstract description 28
- 239000003974 emollient agent Substances 0.000 claims abstract description 22
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 17
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 17
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 17
- 241000246044 Sophora flavescens Species 0.000 claims abstract description 17
- 241000218989 Trichosanthes Species 0.000 claims abstract description 17
- 229940010454 licorice Drugs 0.000 claims abstract description 17
- 241000110847 Kochia Species 0.000 claims abstract description 16
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 16
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 16
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 16
- 229940079593 drug Drugs 0.000 claims abstract description 16
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 16
- 239000010664 perilla essential oil Substances 0.000 claims abstract description 16
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 13
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 13
- 244000089698 Zanthoxylum simulans Species 0.000 claims abstract description 13
- 229940116229 borneol Drugs 0.000 claims abstract description 13
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 13
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 13
- 241001435059 Artemisia argyi Species 0.000 claims abstract description 12
- 235000010894 Artemisia argyi Nutrition 0.000 claims abstract description 12
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 7
- 238000000605 extraction Methods 0.000 claims description 31
- 239000007788 liquid Substances 0.000 claims description 20
- 238000000926 separation method Methods 0.000 claims description 20
- 241000202807 Glycyrrhiza Species 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 11
- 241000213006 Angelica dahurica Species 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 235000002566 Capsicum Nutrition 0.000 claims description 7
- 239000006002 Pepper Substances 0.000 claims description 7
- 235000016761 Piper aduncum Nutrition 0.000 claims description 7
- 235000017804 Piper guineense Nutrition 0.000 claims description 7
- 235000008184 Piper nigrum Nutrition 0.000 claims description 7
- 241000125175 Angelica Species 0.000 claims description 6
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 5
- 240000006891 Artemisia vulgaris Species 0.000 claims description 5
- 241000722363 Piper Species 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 4
- 235000017788 Cydonia oblonga Nutrition 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000007803 itching Effects 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 20
- 230000000249 desinfective effect Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 240000002045 Guettarda speciosa Species 0.000 abstract 1
- 230000002393 scratching effect Effects 0.000 description 10
- 238000006748 scratching Methods 0.000 description 9
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 241000700199 Cavia porcellus Species 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 229960001660 histamine phosphate Drugs 0.000 description 5
- ZHIBQGJKHVBLJJ-UHFFFAOYSA-N histamine phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.NCCC1=CNC=N1 ZHIBQGJKHVBLJJ-UHFFFAOYSA-N 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000008354 sodium chloride injection Substances 0.000 description 4
- 241000700198 Cavia Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010039986 Senile pruritus Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 244000203593 Piper nigrum Species 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 210000000548 hind-foot Anatomy 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000012353 t test Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 241000229722 Perilla <angiosperm> Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229960001803 cetirizine Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000010396 fuzi Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明之目的就是提供一种治疗老年性皮肤瘙痒的止痒润肤精油,是由以下药物混匀制成:花椒精油2‑4ml,艾叶精油2‑4ml,甘草精油2‑4ml,地肤子精油1.5‑2.5ml,苦参精油1.5‑2.5ml,白芷精油1.5‑2.5ml,瓜蒌精油1.5‑2.5ml,紫苏精油1.5‑2.5ml,薄荷精油1.5‑2.5ml及冰片2‑3g;本发明组方科学合理,原料丰富,易生产制备,具有消毒止痒,湿润皮肤之功效,有效用于治疗老年性皮肤瘙痒,疗效好,用药安全,是治疗老年性皮肤瘙痒药物上的创新,有良好的经济和社会效益。The object of the present invention is to provide an antipruritic emollient essential oil for treating senile skin itching, which is made by mixing the following medicines: 2-4ml of Zanthoxylum bungeanum essential oil, 2-4ml of Artemisia argyi essential oil, 2-4ml of licorice essential oil, Kochia chinensis Essential oil 1.5‑2.5ml, Sophora flavescens essential oil 1.5‑2.5ml, Angelica essential oil 1.5‑2.5ml, Trichosanthes essential oil 1.5‑2.5ml, Perilla essential oil 1.5‑2.5ml, Peppermint essential oil 1.5‑2.5ml and borneol 2‑3g; The invented formula is scientific and reasonable, rich in raw materials, easy to produce and prepare, has the effect of disinfecting, relieving itching, and moisturizing the skin, and is effective for treating senile skin itching, with good curative effect and safe medication. Good economic and social benefits.
Description
技术领域technical field
本发明涉及中药,特别是一种治疗老年性皮肤瘙痒的止痒润肤精油。The invention relates to traditional Chinese medicine, in particular to an antipruritic and emollient essential oil for treating senile skin pruritus.
背景技术Background technique
老年性皮肤瘙痒是临床常见疾病,特别是在干燥、寒冷的西北地区,该病的发生率非常高。皮肤瘙痒属于中医学的“痒风”、“风瘙痒”的范畴。皮肤瘙痒症是一种以瘙痒为主要症状,未出现原发性皮肤损害的疾病,患者难以耐受,反复搔抓后可出现继发性抓痕、色素沉着、血痂等临床症状。该病难以彻底治愈,易反复发作,影响患者生活质量。化药治疗虽有一定疗效,但多伴随嗜睡、乏力等不良反应,对工作、生活有影响,现虽有治疗老年性皮肤瘙痒的多种药物,由于种种原因,其治疗效果并不尽人意,因此,其药物上的改进和创新势在必行。Senile pruritus is a common clinical disease, especially in the dry and cold northwest region, the incidence of the disease is very high. Skin pruritus belongs to the category of "itch wind" and "wind pruritus" in traditional Chinese medicine. Pruritus is a disease with pruritus as the main symptom and no primary skin lesions, which is difficult for patients to tolerate, and clinical symptoms such as secondary scratches, pigmentation, and blood crusts may appear after repeated scratching. The disease is difficult to cure completely, and it is easy to recur, which affects the quality of life of patients. Although chemical drug therapy has a certain effect, it is often accompanied by adverse reactions such as drowsiness and fatigue, which have an impact on work and life. Although there are many drugs for the treatment of senile skin itching, the therapeutic effect is not satisfactory due to various reasons. Therefore, improvement and innovation in its medicine is imperative.
发明内容Contents of the invention
针对上述情况,为克服现有技术之缺陷,本发明之目的就是提供一种治疗老年性皮肤瘙痒的止痒润肤精油,可有效解决治疗老年性皮肤瘙痒的用药问题。In view of the above situation, in order to overcome the defects of the prior art, the object of the present invention is to provide an antipruritic emollient essential oil for treating senile skin itching, which can effectively solve the problem of medication for treating senile skin itching.
本发明解决的技术方案是,一种治疗老年性皮肤瘙痒的止痒润肤精油,是由以下药物混匀制成:花椒精油2-4ml,艾叶精油2-4ml,甘草精油2-4ml,地肤子精油1.5-2.5ml,苦参精油1.5-2.5ml,白芷精油1.5-2.5ml,瓜蒌精油1.5-2.5ml,紫苏精油1.5-2.5ml,薄荷精油1.5-2.5ml 及冰片2-3g;The technical scheme solved by the present invention is that an antipruritic emollient essential oil for treating senile skin itching is prepared by mixing the following medicines: 2-4ml of pepper essential oil, 2-4ml of mugwort essential oil, 2-4ml of licorice essential oil, ground Fuzi essential oil 1.5-2.5ml, Sophora flavescens essential oil 1.5-2.5ml, Angelica dahurica essential oil 1.5-2.5ml, Trichosanthes essential oil 1.5-2.5ml, Perilla essential oil 1.5-2.5ml, Peppermint essential oil 1.5-2.5ml and borneol 2-3g ;
所述的花椒精油是,将花椒粉碎成过10~20目筛的粗粉,超临界CO2流体萃取,料液重量体积比1:10~20,重量体积比是指固体以g计,液体以mL计,萃取温度42~50℃,萃取压力20~25MPa,分离温度50~60℃,分离压力4.5~5.5MPa,萃取时间1.5~2.5h,得花椒精油;The described Zanthoxylum bungeanum essential oil is that Zanthoxylum bungeanum is pulverized into coarse powder passing through a 10-20 mesh sieve, extracted with supercritical CO2 fluid, and the weight-to-volume ratio of material to liquid is 1:10-20, and the weight-to-volume ratio refers to solid in g, liquid In mL, the extraction temperature is 42-50°C, the extraction pressure is 20-25MPa, the separation temperature is 50-60°C, the separation pressure is 4.5-5.5MPa, the extraction time is 1.5-2.5h, and the pepper essential oil is obtained;
所述的艾叶精油是,将艾叶粉碎成过10~20目筛的粗粉,超临界CO2流体萃取,料液重量体积比1:10~20,重量体积比是指固体以g计,液体以mL计,萃取温度42~50℃,萃取压力20~25MPa,分离温度50~60℃,分离压力4.5~5.5MPa,萃取时间1.5~2.5h,得艾叶精油;The described Artemisia argyi essential oil is that Artemisia argyi is crushed into a coarse powder passing through a 10-20 mesh sieve, extracted with supercritical CO2 fluid, and the weight-to-volume ratio of material to liquid is 1:10-20, and the weight-to-volume ratio refers to solid in g, liquid In mL, the extraction temperature is 42-50°C, the extraction pressure is 20-25MPa, the separation temperature is 50-60°C, the separation pressure is 4.5-5.5MPa, and the extraction time is 1.5-2.5h, to obtain Artemisia argyi essential oil;
所述的甘草精油是,将甘草粉碎成过10~20目筛的粗粉,超临界CO2流体萃取,料液重量体积比1:10~20,重量体积比是指固体以g计,液体以mL计,萃取温度42~50℃,萃取压力20~25MPa,分离温度50~60℃,分离压力4.5~5.5MPa,萃取时间1.5~2.5h,得甘草精油;The licorice essential oil is that the licorice is crushed into coarse powder passing through a 10-20 mesh sieve, extracted with supercritical CO2 fluid, and the weight-to-volume ratio of material to liquid is 1:10-20. The weight-to-volume ratio refers to the solid in g and the liquid In mL, the extraction temperature is 42-50°C, the extraction pressure is 20-25MPa, the separation temperature is 50-60°C, the separation pressure is 4.5-5.5MPa, the extraction time is 1.5-2.5h, and the licorice essential oil is obtained;
所述的地肤子精油是,将地肤子粉碎成过10~20目筛的粗粉,超临界CO2流体萃取,料液重量体积比1:10~20,重量体积比是指固体以g计,液体以mL计,萃取温度42~50℃,萃取压力20~25MPa,分离温度50~60℃,分离压力4.5~5.5MPa,萃取时间1.5~2.5h,得地肤子精油;The Kochia scoparia essential oil is that the Kochia scopariae is crushed into coarse powder passing through a 10-20 mesh sieve, extracted with supercritical CO2 fluid, and the weight-to-volume ratio of material to liquid is 1:10-20, and the weight-to-volume ratio refers to solid to In g, liquid in mL, extraction temperature 42-50°C, extraction pressure 20-25MPa, separation temperature 50-60°C, separation pressure 4.5-5.5MPa, extraction time 1.5-2.5h, to obtain Kochia scoparia essential oil;
所述的苦参精油是,将苦参粉碎成过10~20目筛的粗粉,超临界CO2流体萃取,料液重量体积比1:10~20,重量体积比是指固体以g计,液体以mL计,萃取温度42~50℃,萃取压力20~25MPa,分离温度50~60℃,分离压力4.5~5.5MPa,萃取时间1.5~2.5h,得苦参精油;The described Sophora flavescens essential oil is that Sophora flavescens is crushed into coarse powder passing through a 10-20 mesh sieve, extracted with supercritical CO2 fluid, and the weight-to-volume ratio of material to liquid is 1:10-20, and the weight-to-volume ratio refers to the solid in g , the liquid is measured in mL, the extraction temperature is 42-50°C, the extraction pressure is 20-25MPa, the separation temperature is 50-60°C, the separation pressure is 4.5-5.5MPa, and the extraction time is 1.5-2.5h to obtain Sophora flavescens essential oil;
所述的白芷精油是,将白芷粉碎成过10~20目筛的粗粉,超临界CO2流体萃取,料液重量体积比1:10~20,重量体积比是指固体以g计,液体以mL计,萃取温度42~50℃,萃取压力20~25MPa,分离温度50~60℃,分离压力4.5~5.5MPa,萃取时间1.5~2.5h,得白芷精油;The described Angelica dahurica essential oil is that the Angelica dahurica is crushed into a coarse powder passing through a 10-20 mesh sieve, extracted with supercritical CO2 fluid, and the weight-to-volume ratio of material to liquid is 1:10-20, and the weight-to-volume ratio refers to the solid in g, and the liquid In mL, the extraction temperature is 42-50°C, the extraction pressure is 20-25MPa, the separation temperature is 50-60°C, the separation pressure is 4.5-5.5MPa, the extraction time is 1.5-2.5h, and the essential oil of Angelica dahurica is obtained;
所述的瓜蒌精油是,将瓜蒌粉碎成过10~20目筛的粗粉,超临界CO2流体萃取,料液重量体积比1:10~20,重量体积比是指固体以g计,液体以mL计,萃取温度42~50℃,萃取压力20~25MPa,分离温度50~60℃,分离压力4.5~5.5MPa,萃取时间1.5~2.5h,得瓜蒌精油;Described trichosanthes essential oil is that trichosanthes is pulverized into the coarse powder of passing through 10~20 mesh sieves, supercritical CO 2 fluid extraction, material-liquid weight-volume ratio 1:10~20, and weight-volume ratio refers to the solid in g , the liquid is measured in mL, the extraction temperature is 42-50°C, the extraction pressure is 20-25MPa, the separation temperature is 50-60°C, the separation pressure is 4.5-5.5MPa, the extraction time is 1.5-2.5h, and the Trichosanthes essential oil is obtained;
所述的紫苏精油是,将紫苏粉碎成过10~20目筛的粗粉,超临界CO2流体萃取,料液重量体积比1:10~20,重量体积比是指固体以g计,液体以mL计,萃取温度42~50℃,萃取压力20~25MPa,分离温度50~60℃,分离压力4.5~5.5MPa,萃取时间1.5~2.5h,得紫苏精油;The perilla essential oil is that perilla is crushed into a coarse powder passing through a 10-20 mesh sieve, extracted with supercritical CO2 fluid, and the weight-to-volume ratio of material to liquid is 1:10-20, and the weight-to-volume ratio refers to the solid in g , the liquid is measured in mL, the extraction temperature is 42-50°C, the extraction pressure is 20-25MPa, the separation temperature is 50-60°C, the separation pressure is 4.5-5.5MPa, the extraction time is 1.5-2.5h, and perilla essential oil is obtained;
所述的薄荷精油是,将薄荷粉碎成过10~20目筛的粗粉,超临界CO2流体萃取,料液重量体积比1:10~20,重量体积比是指固体以g计,液体以mL计,萃取温度42~50℃,萃取压力20~25MPa,分离温度50~60℃,分离压力4.5~5.5MPa,萃取时间1.5~2.5h,得薄荷精油。The peppermint essential oil is as follows: mint is crushed into a coarse powder passing through a 10-20 mesh sieve, extracted with supercritical CO2 fluid, the weight-to-volume ratio of material to liquid is 1:10-20, and the weight-to-volume ratio refers to the solid in g, the liquid In mL, the extraction temperature is 42-50°C, the extraction pressure is 20-25MPa, the separation temperature is 50-60°C, the separation pressure is 4.5-5.5MPa, and the extraction time is 1.5-2.5h to obtain peppermint essential oil.
本发明组方科学合理,原料丰富,易生产制备,具有消毒止痒,湿润皮肤之功效,有效用于治疗老年性皮肤瘙痒,疗效好,用药安全,是治疗老年性皮肤瘙痒药物上的创新,有良好的经济和社会效益。The prescription of the present invention is scientific and reasonable, has abundant raw materials, is easy to produce and prepare, has the effects of disinfecting, relieving itching, and moisturizing the skin, and is effectively used for treating senile skin itching, with good curative effect and safe medication, and is an innovation in medicine for treating senile skin itching. There are good economic and social benefits.
具体实施方式Detailed ways
以下结合具体情况和实施例对本发明的具体实施方式做详细说明。The specific implementation of the present invention will be described in detail below in combination with specific conditions and examples.
本发明具体实施方式可由以下实施例给出。Specific embodiments of the present invention can be given by the following examples.
实施例1:本发明一种治疗老年性皮肤瘙痒的止痒润肤精油,是由以下药物混匀制成:花椒精油3ml,艾叶精油3ml,甘草精油3ml,地肤子精油2ml,苦参精油2ml,白芷精油2ml,瓜蒌精油2ml,紫苏精油2ml,薄荷精油2ml及冰片3g。Embodiment 1: A kind of antipruritic emollient essential oil for treating senile skin pruritus of the present invention is made by mixing the following medicines: 3ml of Zanthoxylum bungeanum essential oil, 3ml of Artemisia argyi essential oil, 3ml of licorice essential oil, 2ml of Kochia scoparia essential oil, Sophora flavescens essential oil 2ml, Angelica essential oil 2ml, Trichosanthes essential oil 2ml, perilla essential oil 2ml, peppermint essential oil 2ml and borneol 3g.
实施例2:本发明一种治疗老年性皮肤瘙痒的止痒润肤精油,是由以下药物混匀制成:花椒精油2ml,艾叶精油2ml,甘草精油2ml,地肤子精油1.5ml,苦参精油1.5ml,白芷精油1.5ml,瓜蒌精油1.5ml,紫苏精油1.5ml,薄荷精油1.5ml及冰片2g。Embodiment 2: A kind of antipruritic emollient essential oil for treating senile skin pruritus of the present invention is made by mixing the following medicines: 2ml of Zanthoxylum bungeanum essential oil, 2ml of Artemisia argyi essential oil, 2ml of licorice essential oil, 1.5ml of Kochia scoparia essential oil, Sophora flavescens Essential oil 1.5ml, Angelica essential oil 1.5ml, Trichosanthes essential oil 1.5ml, Perilla essential oil 1.5ml, Peppermint essential oil 1.5ml and borneol 2g.
实施例3:本发明一种治疗老年性皮肤瘙痒的止痒润肤精油,是由以下药物混匀制成:花椒精油4ml,艾叶精油4ml,甘草精油4ml,地肤子精油2.5ml,苦参精油2.5ml,白芷精油2.5ml,瓜蒌精油2.5ml,紫苏精油2.5ml,薄荷精油2.5ml及冰片3g。Embodiment 3: A kind of antipruritic emollient essential oil for treating senile skin pruritus of the present invention is made by mixing the following medicines: 4ml of Zanthoxylum bungeanum essential oil, 4ml of Artemisia argyi essential oil, 4ml of licorice essential oil, 2.5ml of Kochia scoparia essential oil, Sophora flavescens Essential oil 2.5ml, Angelica essential oil 2.5ml, Trichosanthes essential oil 2.5ml, Perilla essential oil 2.5ml, Peppermint essential oil 2.5ml and borneol 3g.
实施例4:本发明一种治疗老年性皮肤瘙痒的止痒润肤精油,是由以下药物混匀制成:花椒精油2ml,艾叶精油4ml,甘草精油2ml,地肤子精油2.5ml,苦参精油1.5ml,白芷精油2.5ml,瓜蒌精油1.5ml,紫苏精油2.5ml,薄荷精油1.5ml及冰片3g。Embodiment 4: A kind of antipruritic emollient essential oil for treating senile skin pruritus of the present invention is made by mixing the following medicines: 2ml of Zanthoxylum bungeanum essential oil, 4ml of Artemisia argyi essential oil, 2ml of licorice essential oil, 2.5ml of Kochia scoparia essential oil, Sophora flavescens Essential oil 1.5ml, Angelica essential oil 2.5ml, Trichosanthes essential oil 1.5ml, Perilla essential oil 2.5ml, Peppermint essential oil 1.5ml and borneol 3g.
实施例5:本发明一种治疗老年性皮肤瘙痒的止痒润肤精油,是由以下药物混匀制成:花椒精油4ml,艾叶精油2ml,甘草精油4ml,地肤子精油1.5ml,苦参精油2.5ml,白芷精油1.5ml,瓜蒌精油2.5ml,紫苏精油1.5ml,薄荷精油2.5ml及冰片2g。Embodiment 5: A kind of antipruritic emollient essential oil for treating senile skin pruritus of the present invention is made by mixing the following medicines: 4ml of Zanthoxylum bungeanum essential oil, 2ml of Artemisia argyi essential oil, 4ml of licorice essential oil, 1.5ml of Kochia scoparia essential oil, Sophora flavescens Essential oil 2.5ml, Angelica essential oil 1.5ml, Trichosanthes essential oil 2.5ml, Perilla essential oil 1.5ml, Peppermint essential oil 2.5ml and borneol 2g.
本发明经试验和实地应用取得了非常好的效果:有关试验资料如下:The present invention has obtained very good effect through test and field application: relevant test data are as follows:
一、动物试验:1. Animal test:
1实验材料1 Experimental materials
1.1实验仪器:1.1 Experimental equipment:
FA(N)/JA(N)系列电子天平,上海民桥精密仪器有限公司;FA(N)/JA(N) series electronic balance, Shanghai Minqiao Precision Instrument Co., Ltd.;
1.2实验试剂:1.2 Experimental reagents:
本发明止痒润肤精油。肤得安,沈阳康氏医药保健品有限公生产。脱毛膏,上海诗碧化妆品有限公司生产。氯化钠注射液,山东华鲁制药有限公司生产。右旋糖酐,北京索莱宝科技有限公司生产。The antipruritic and emollient essential oil of the present invention. Fudean is produced by Shenyang Kangshi Pharmaceutical and Health Products Co., Ltd. Hair removal cream, produced by Shanghai Shibi Cosmetics Co., Ltd. Sodium chloride injection was produced by Shandong Hualu Pharmaceutical Co., Ltd. Dextran, produced by Beijing Suolaibao Technology Co., Ltd.
1.3实验动物1.3 Experimental animals
20-22g KM小鼠,雌雄各半,SPF级,质量合格证No.37009200007439,山东省实验动物中心许可证号SCXK鲁20140007。实验单位使用许可证编号SYXK(豫)2015-0005。20-22g KM mice, half male and half female, SPF grade, quality certificate No. 37009200007439, Shandong Provincial Experimental Animal Center license number SCXK Lu 20140007. The experimental unit uses the license number SYXK (Yu) 2015-0005.
2实验方法2 Experimental methods
2.1动物饲养2.1 Animal feeding
温度22‐26℃,湿度40‐60%,人工照明12小时白天与12小时黑夜交替,给予常规的实验室饮食,不限制饮水。The temperature was 22-26°C, the humidity was 40-60%, the artificial lighting was 12 hours day and 12 hours night alternately, and a normal laboratory diet was given without restriction on drinking water.
2.2实验方法2.2 Experimental method
取KM小鼠48只,雌雄各半,随机分为4组,每组12只,即模型组、肤得安组,大、小剂量止痒润肤精油组。给药前1d脱去小鼠腹部皮肤的毛备用,然后去毛处皮肤涂抹给药,模型组敷0.9%氯化钠注射液(0.3ml,分两次涂,每次0.15ml),大、小剂量止痒润肤精油组(原精油、用液体石蜡稀释一倍精油,均为0.3ml,分两次涂,每次0.15ml),肤得安组涂肤得安药膏0.3g(厚度为2mm)。30min(各组均为先涂一次,15min再涂一次)。然后各组小鼠尾静脉注射0.025%右旋糖酐5mL·kg-1(1.25mg·kg-1),即得小鼠瘙痒模型。以小鼠前爪搔头部、后爪搔躯干、嘴咬全身各部位作为瘙痒指征。Take 48 KM mice, half male and half male, and randomly divide them into 4 groups, 12 mice in each group, that is, the model group, the Fudean group, and the large and small dose antipruritic and emollient essential oil groups. 1 d before the administration, the hair of the abdominal skin of the mouse was removed for subsequent use, and then the skin of the depilated place was smeared for administration, and the model group was applied with 0.9% sodium chloride injection (0.3ml, divided into two times, 0.15ml each time). Small dose antipruritic emollient essential oil group (0.3ml of the original essential oil and one-fold dilution of essential oil with liquid paraffin, applied twice, 0.15ml each time), Fude'an ointment 0.3g (thickness: 2mm). 30min (all groups are painted once, 15min and then again). Then mice in each group were injected with 0.025% dextran 5 mL·kg-1 (1.25 mg·kg-1) through the tail vein to obtain a mouse pruritus model. Scratching the head with front paws, scratching the trunk with hind paws, and biting various parts of the whole body were used as indications of itching.
记录瘙痒潜伏期(注射结束至第1次搔抓开始的时间)、第1次挠痒后30min内小鼠瘙痒次数。以小鼠后肢持续搔抓注射部位至停止记作1次搔抓(连续播抓记作1次)。瘙痒次数:自瘙痒模型小鼠第1次发生挠痒动作起,记录30min内的挠痒总次数。The itching latency period (the time from the end of the injection to the start of the first scratching) and the number of itching of the mice within 30 min after the first scratching were recorded. Scratching the injection site with the mouse's hind limbs until it stopped was counted as 1 scratch (continuous scratching was counted as 1 time). Times of itching: since the first scratching action of the pruritus model mice, record the total number of times of scratching within 30 minutes.
2.3统计学方法2.3 Statistical methods
实验数据用SPSS21统计软件处理,数据以表示,组间比较采用t检验。The experimental data was processed with SPSS21 statistical software, and the data was The t test was used for comparison between groups.
3实验结果3 Experimental results
表1中药止痒方对小鼠瘙痒模型的影响Table 1 The effect of traditional Chinese medicine Zhiyang prescription on the pruritus model in mice
注:**P<0.01,*P<0.05,表示与模型组相比Note: **P<0.01, *P<0.05, compared with the model group
从上表可看出,与模型组比较,大、小剂量止痒润肤精油组和肤得安组均可显著延长小鼠首次瘙痒时间(P<0.01),显著减少小鼠瘙痒次数(P<0.01)。It can be seen from the above table that compared with the model group, the large and small doses of antipruritic emollient essential oil group and Fudean group can significantly prolong the time of the first itching in mice (P<0.01), and significantly reduce the number of itching in mice (P<0.01). <0.01).
二、对豚鼠皮肤瘙痒模型的影响2. The effect on guinea pig pruritus model
1实验材料1 Experimental materials
1.1实验仪器:1.1 Experimental equipment:
FA(N)/JA(N)系列电子天平,上海民桥精密仪器有限公司;FA(N)/JA(N) series electronic balance, Shanghai Minqiao Precision Instrument Co., Ltd.;
1.2实验试剂:1.2 Experimental reagents:
本发明精油。肤得安,沈阳康氏医药保健品有限公司生产。脱毛膏,上海诗碧化妆品有限公司生产。氯化钠注射液,山东华鲁制药有限公司生产。磷酸组胺,源叶生物生物科技有限公司生产。Essential oil of the present invention. Fudean is produced by Shenyang Kangshi Pharmaceutical and Health Products Co., Ltd. Hair removal cream, produced by Shanghai Shibi Cosmetics Co., Ltd. Sodium chloride injection was produced by Shandong Hualu Pharmaceutical Co., Ltd. Histamine phosphate, produced by Yuanye Biotechnology Co., Ltd.
1.3实验动物1.3 Experimental animals
豚鼠,体质量250~280g,雌雄各半,普通级,山东省实验动物中心质量合格证:NO.37009200000334,许可证号:SCXK鲁20140007。实验单位使用许可证编号:SYXK(豫)2015-0005。Guinea pigs, body weight 250-280g, half male and half male, normal grade, quality certificate of Shandong Experimental Animal Center: NO.37009200000334, license number: SCXK Lu 20140007. Experimental unit use license number: SYXK (Yu) 2015-0005.
2实验方法2 Experimental methods
2.1动物饲养:2.1 Animal feeding:
温度22‐26℃,湿度40‐60%,人工照明12小时白天与12小时黑夜交替,给予常规的实验室饮食,不限制饮水。The temperature was 22-26°C, the humidity was 40-60%, the artificial lighting was 12 hours day and 12 hours night alternately, and a normal laboratory diet was given without restriction on drinking water.
2.2实验方法2.2 Experimental method
取健康豚鼠48只,雌雄各半,250~280g。随机分为4组,每组12只,分别为:模型组,肤得安组,大、小剂量止痒润肤精油组。动物右后足脱毛24h后,分别在各豚鼠右后足背脱毛部位给药,大小剂量止痒润肤精油组(原精油、用液体石蜡稀释一倍精油,均为0.15ml),肤得安组敷肤得安药膏0.3g(厚度为2mm),模型组敷0.9%氯化钠注射液0.3mL。保持15min。15min后用纱布磨擦局部至有渗血点(以渗血、无明显出血为度),面积1cm2,再同法同量给相应药1次,并于给药后10min开始,分别在创面处涂抹0.01%磷酸组织胺50μL,以后每隔3min在相同部位再依次滴浓度递增为0.02%、0.03%、0.04%……等量磷酸组织胺,直至出现豚鼠回头舔足为止,以此段时间内给各动物所滴的磷酸组织胺的总量为致痒阈,如滴至0.1%磷酸组织胺豚鼠仍未舔后足,则以滴加总量为致痒阈,比较各组的致痒阈。Take 48 healthy guinea pigs, half male and half male, 250-280g. They were randomly divided into 4 groups, 12 rats in each group, namely: model group, Fudean group, large and small dose antipruritic emollient essential oil groups. After 24 hours of depilation of the animal's right hind foot, the drug was administered to the depilated part of the right hind foot of each guinea pig respectively. In the large and small doses of antipruritic and emollient essential oil group (0.15ml of the original essential oil and one-fold dilution of essential oil with liquid paraffin), Fudean 0.3 g of Fude'an Ointment (thickness: 2 mm) was applied in the model group, and 0.3 mL of 0.9% sodium chloride injection was applied in the model group. Keep it for 15min. After 15 minutes, rub the local area with gauze until there is bleeding point (the degree of bleeding and no obvious bleeding), with an area of 1 cm 2 , and then give the corresponding drug once in the same way, and start 10 minutes after the administration, respectively on the wound surface Apply 50 μL of 0.01% histamine phosphate, and then drop the same amount of histamine phosphate every 3 minutes on the same part in order to increase the concentration to 0.02%, 0.03%, 0.04%, until the guinea pig turns back and licks the foot, during this period of time The total amount of histamine phosphate dripped to each animal is the itching threshold. If the guinea pig has not licked the hind feet after dripping to 0.1% histamine phosphate, the total amount of the dropping is the itching threshold, and the itching threshold of each group is compared. .
2.3统计学方法2.3 Statistical methods
实验数据用SPSS21统计软件处理,数据以表示,组间比较采用t检验。The experimental data was processed with SPSS21 statistical software, and the data was The t test was used for comparison between groups.
3实验结果3 Experimental results
表2中药止痒方对豚鼠瘙痒模型的影响Table 2 The effect of traditional Chinese medicine Zhiyang prescription on guinea pig pruritus model
注:**P<0.01,表示与模型组相比Note: **P<0.01, compared with the model group
从上表可看出,与模型组比较,大、小剂量止痒润肤精油组和肤得安组均可明显升高豚鼠的致痒域(P<0.01)。It can be seen from the above table that compared with the model group, both the large and small doses of antipruritic emollient essential oil group and Fudean group can significantly increase the itching domain of guinea pigs (P<0.01).
二、临床试验:2. Clinical trials:
在确保动物试验安全的基础上,在临床上经试用,也取得了非常满意的有益技术效果,有关资料如下:On the basis of ensuring the safety of animal experiments, it has also achieved very satisfactory beneficial technical effects through clinical trials. The relevant information is as follows:
1、选择病例的标准:1. Criteria for selecting cases:
老年性皮肤瘙痒是临床常见疾病,特别是在干燥、寒冷的西北地区,该病的发生率非常高。皮肤瘙痒属于中医学的“痒风”、“风瘙痒”的范畴。皮肤瘙痒症是一种以瘙痒为主要症状,未出现原发性皮肤损害的疾病,患者难以耐受,反复搔抓后可出现继发性抓痕、色素沉着、血痂等临床症状。凡具有上述症状者,均作为选择病例的标准。Senile pruritus is a common clinical disease, especially in the dry and cold northwest region, the incidence of the disease is very high. Skin pruritus belongs to the category of "itch wind" and "wind pruritus" in traditional Chinese medicine. Pruritus is a disease with pruritus as the main symptom and no primary skin lesions, which is difficult for patients to tolerate, and clinical symptoms such as secondary scratches, pigmentation, and blood crusts may appear after repeated scratching. Those who have the above symptoms are used as the criteria for selecting cases.
2、诊断标准:2. Diagnostic criteria:
凡具有上述症状,经诊断化验,即可确诊为患有老年性皮肤瘙痒,并给予本发明药物治疗。All have above-mentioned symptoms, can be diagnosed as suffering from senile pruritus through diagnostic test, and give medicine treatment of the present invention.
3、治疗方案:3. Treatment plan:
对确诊的患者采用本发明药物治疗,每天两次,早晚各一次,涂于患处,连续两周为一疗程,并在试验的同时设对照组,对照组口服西替利嗪,10mg/次,每天一次,两组治疗期间均合理调整饮食,减少洗澡次数,禁用碱性肥皂,着宽松棉质衣物。Adopt the present invention's medicine treatment to the patient of diagnosis, every day twice, each once sooner or later, be applied to affected part, continuous two weeks is a course for the treatment of, and establish control group while test, control group is oral cetirizine, 10mg/time, Once a day. During the treatment period, the two groups adjusted their diet reasonably, reduced the number of baths, banned alkaline soap, and wore loose cotton clothes.
4、疗效评定标准:4. Criteria for evaluation of curative effect:
疗效程度评分采用视觉模拟量表(VAS)评估两组患者瘙痒程度,(1~3)分为轻度,(4~ 6)分为中度,(7~10分为重度。The degree of curative effect was scored by visual analog scale (VAS) to evaluate the degree of itching in the two groups, (1-3) was divided into mild, (4-6) was divided into moderate, (7-10 was divided into severe.
疗效判定对患者瘙痒程度、发生频率、持续时间、瘙痒面积等进行分级评分,0分为无,5分为轻,10分为中,15分为重,统计治疗前后各项得分总和。疗效指数=(治疗前总分-治疗后总分)/治疗前总分×100%。疗效指数≥95%为痊愈;70%≤疗效指数<95%为显效;30%≤疗效指数<70%为有效;疗效指数<30%为无效。总有效率=(痊愈+显效+ 有效)/总例数×100%。Judgment of curative effect Graded and scored the degree of itching, frequency of occurrence, duration, and area of itching, with 0 being none, 5 being mild, 10 being moderate, and 15 being severe. The total scores before and after treatment were counted. Curative effect index=(total score before treatment-total score after treatment)/total score before treatment×100%. Curative effect index ≥ 95% is cured; 70% ≤ curative index < 95% is markedly effective; 30% ≤ curative index < 70% is effective; curative index < 30% is ineffective. Total effective rate=(cured+markedly effective+effective)/total number of cases×100%.
5、统计学处理:5. Statistical processing:
经对确诊的56例患者,随机分为本发明组和对照组,各28例,其中,瘙痒程度:本发明28例,治疗前VAS评分7.8±1.6,治疗后2.1±0.9;对照组28例,治疗前VAS评分7.7 ±1.5,治疗后3.9±1.2。The 56 patients who were diagnosed were randomly divided into the present invention group and the control group, each with 28 cases, wherein, the degree of itching: 28 cases in the present invention, the VAS score before treatment was 7.8 ± 1.6, and 2.1 ± 0.9 after treatment; 28 cases in the control group , the VAS score was 7.7±1.5 before treatment and 3.9±1.2 after treatment.
本发明组28例,痊愈9例(32.1%),显效13例(46.4%),有效4例(14.3%),无效 2例(7.1%),总有效率92.9%。对照组28例,痊愈2例(7.1%),显效10例(35.7%),有效8例(28.6%),无效8例(28.6%),总有效率71.4%。并且在试验期间,未发现任何不良反应和毒副作用。In the present invention group of 28 cases, 9 cases (32.1%) were cured, 13 cases (46.4%) were markedly effective, 4 cases (14.3%) were effective, 2 cases (7.1%) were ineffective, and the total effective rate was 92.9%. Of the 28 cases in the control group, 2 cases (7.1%) were cured, 10 cases (35.7%) were markedly effective, 8 cases (28.6%) were effective, and 8 cases (28.6%) were ineffective, and the total effective rate was 71.4%. And during the test, no adverse reactions and side effects were found.
6、结论:由上述可以看出,本发明组方科学合理,原料丰富,易生产制备,具有消毒止痒,湿润皮肤之功效,有效用于治疗老年性皮肤瘙痒,疗效好,疗效高达92%以上,疗效稳定可靠,用药安全,是治疗老年性皮肤瘙痒药物上的创新,有良好的经济和社会效益。6. Conclusion: It can be seen from the above that the prescription of the present invention is scientific and reasonable, rich in raw materials, easy to produce and prepare, has the effect of disinfecting and relieving itching, and moisturizing the skin, and is effective for treating senile skin itching, with good curative effect, and the curative effect is as high as 92%. Above, the curative effect is stable and reliable, and the medication is safe. It is an innovation in the treatment of senile skin pruritus, and has good economic and social benefits.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810926128.9A CN108686023A (en) | 2018-08-15 | 2018-08-15 | A kind of antipruritic moisturizing essential oil for treating geroderma itch |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810926128.9A CN108686023A (en) | 2018-08-15 | 2018-08-15 | A kind of antipruritic moisturizing essential oil for treating geroderma itch |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108686023A true CN108686023A (en) | 2018-10-23 |
Family
ID=63841552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810926128.9A Withdrawn CN108686023A (en) | 2018-08-15 | 2018-08-15 | A kind of antipruritic moisturizing essential oil for treating geroderma itch |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108686023A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110420242A (en) * | 2019-07-25 | 2019-11-08 | 南京中医药大学 | A kind of development of novel antipruritic essential oil |
CN112120970A (en) * | 2020-09-29 | 2020-12-25 | 上海相宜本草化妆品股份有限公司 | Essential oil composition, preparation method and application thereof |
CN113234345A (en) * | 2021-05-26 | 2021-08-10 | 中山市富日印刷材料有限公司 | Environment-friendly efficient cleaning agent and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107875190A (en) * | 2017-12-25 | 2018-04-06 | 河南中医药大学 | A kind of Chinese medicine preparation essential oil of external curing senile skin itch |
-
2018
- 2018-08-15 CN CN201810926128.9A patent/CN108686023A/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107875190A (en) * | 2017-12-25 | 2018-04-06 | 河南中医药大学 | A kind of Chinese medicine preparation essential oil of external curing senile skin itch |
Non-Patent Citations (1)
Title |
---|
杨祖顺等: "一种杀菌气雾剂的消毒效果及毒性试验 ", 《中国消毒学杂志》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110420242A (en) * | 2019-07-25 | 2019-11-08 | 南京中医药大学 | A kind of development of novel antipruritic essential oil |
CN112120970A (en) * | 2020-09-29 | 2020-12-25 | 上海相宜本草化妆品股份有限公司 | Essential oil composition, preparation method and application thereof |
CN112120970B (en) * | 2020-09-29 | 2023-02-03 | 上海相宜本草化妆品股份有限公司 | Chinese herbal medicine essential oil composition with permeation promoting effect, preparation method and application thereof |
CN113234345A (en) * | 2021-05-26 | 2021-08-10 | 中山市富日印刷材料有限公司 | Environment-friendly efficient cleaning agent and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100464782C (en) | Remedy for fibromyalgia | |
JP2004508404A (en) | Analgesic techniques | |
US20150038568A1 (en) | Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis | |
CN108686023A (en) | A kind of antipruritic moisturizing essential oil for treating geroderma itch | |
CN117159620A (en) | Essential oil for weight loss and preparation method and application thereof | |
WO2023024632A1 (en) | Pharmaceutical composition for treating allergic rhinitis and preparation method therefor | |
CN102579621A (en) | Chinese medicinal preparation for treating urinary calculus of goat | |
CN104524247B (en) | One treats migrainous medical composition and its use | |
CN106822377A (en) | A kind of compound osteitis bar cloth patch and preparation method thereof | |
CN104523925B (en) | Traditional Chinese medicinal composition and its application in defecation promotion | |
CN107875190A (en) | A kind of Chinese medicine preparation essential oil of external curing senile skin itch | |
JP3884693B2 (en) | Formulations and functional foods that contain ultrafine powdered negative ion generating materials and far-infrared generating materials as active ingredients | |
CN108743460A (en) | A kind of ecchymose removing essential oil for treating chloasma | |
CN1238032C (en) | Tincture for curing acne and preparation method | |
CN107496525A (en) | A kind of Chinese medicine composition for treating cancer pain disease and its application | |
CN103041194B (en) | Traditional Chinese medicine composition for curing chronic eczema and preparation method thereof | |
CN107080786A (en) | Antidepressant compositions and its preparation method and application and medicine or pharmaceutical composition comprising it | |
CN106177508A (en) | The Chinese medicine external ointment for the treatment of radioactive skin injury | |
CN101940652B (en) | Chinese medicinal liniment for treating psoriasis, multiple kinds of stubborn dermatitis and pruritus | |
CN104274540B (en) | Chinese medicine composition, preparation method and use containing tripterygium wilfordii | |
CN101564433B (en) | Chinese medicinal composition for treating rheumatic diseases, and preparation method thereof | |
CN104784627A (en) | Traditional Chinese medicine externally used film agent used for treatment surgical open or closed injury and preparation method thereof | |
JPH10120556A (en) | Skin preparation for improving sputum for external use | |
CN108404094A (en) | A kind of thin network analgesic antiphlogistic bee venom application conditioning cream | |
CN104001057A (en) | Medicine for treating heart and kidney imbalanced schizophrenia and preparing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20181023 |